Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Week In Review: BioKangtai Acquires China Rights To AstraZeneca's COVID-19 Vaccine [Seeking Alpha]

Denali Therapeutics Inc. (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com
Company Research Source: Seeking Alpha
SummaryBioKangtai, a Guangdong vaccine company, in-licensed rights to develop, manufacture and market AstraZeneca's COVID-19 vaccine in China.Biogen announced a $2 billion blockbuster deal to partner Denali Therapeutics' potential Parkinson's Disease therapy.Nanjing Simcere Pharma in-licensed Greater China rights to trilaciclib from North Carolina's GI Therapeutics in a $170 million agreement.COVID-19 PandemicBioKangtai (SHZ: 300601), a Guangdong vaccine company, in-licensed(NYSE:AZNShanghai Fosun Pharma (SHA: 600196; HK; 02196)reported(NASDAQ:BNTXPFEDeals and FinancingsBIIBDNLISherpa Healthcare Partners of Beijing closed its first US dollar fund with $200 million in capital, which Sherpa said was oversubscribed. The Oregon Public Employees System (PERS) committed $100 million of the total. Sherpa will focus on early- to growth-stage investments in biotech, biopharma, medical device and medical service companies in both China and the US. It has already completed investments in eight Show less Read more
Impact Snapshot
Event Time:
DNLI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for DNLI alerts
Opt-in for
DNLI alerts

from News Quantified
Opt-in for
DNLI alerts

from News Quantified